{
    "id": 25429,
    "fullName": "TSC1 L116fs",
    "impact": "frameshift",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "TSC1 L116fs results in a change in the amino acid sequence of the Tsc1 protein beginning at aa 116 of 1164, likely resulting in premature truncation of the functional protein (UniProt.org). Due to the loss of most known functional domains (UniProt.org), L116fs is predicted to lead to a loss of Tsc1 protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7248,
        "geneSymbol": "TSC1",
        "terms": [
            "TSC1",
            "LAM",
            "TSC"
        ]
    },
    "variant": "L116fs",
    "createDate": "09/26/2016",
    "updateDate": "10/07/2018",
    "referenceTranscriptCoordinates": {
        "id": 119895,
        "transcript": "NM_000368",
        "gDna": "chr9:g.132925602delT",
        "cDna": "c.348delA",
        "protein": "p.L116fs*2",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8525,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, EGFR L858R and TSC1 L116fs*2 were identified in a lung adenocarcinoma patient who acquired resistance to Gilotrif (afatinib) and Erbitux (cetuximab) combination treatment (PMID: 24813888).",
            "molecularProfile": {
                "id": 26348,
                "profileName": "EGFR L858R TSC1 L116fs"
            },
            "therapy": {
                "id": 4190,
                "therapyName": "Afatinib + Cetuximab",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 4088,
                    "pubMedId": 24813888,
                    "title": "Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24813888"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26347,
            "profileName": "TSC1 L116fs",
            "profileTreatmentApproaches": [
                {
                    "id": 10631,
                    "name": "mTOR Inhibitor",
                    "profileName": "TSC1 L116fs"
                },
                {
                    "id": 10632,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "TSC1 L116fs"
                }
            ]
        },
        {
            "id": 26348,
            "profileName": "EGFR L858R TSC1 L116fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 119894,
            "transcript": "NM_001162426",
            "gDna": "chr9:g.132925602delT",
            "cDna": "c.348delA",
            "protein": "p.L116fs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119900,
            "transcript": "XM_005272211",
            "gDna": "chr9:g.132925602delT",
            "cDna": "c.348delA",
            "protein": "p.L116fs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119897,
            "transcript": "XM_017015097",
            "gDna": "chr9:g.132925602delT",
            "cDna": "c.348delA",
            "protein": "p.L116fs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119895,
            "transcript": "NM_000368",
            "gDna": "chr9:g.132925602delT",
            "cDna": "c.348delA",
            "protein": "p.L116fs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119899,
            "transcript": "XM_017015098",
            "gDna": "chr9:g.132925602delT",
            "cDna": "c.348delA",
            "protein": "p.L116fs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119901,
            "transcript": "XM_006717271",
            "gDna": "chr9:g.132925602delT",
            "cDna": "c.348delA",
            "protein": "p.L116fs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119898,
            "transcript": "XM_017015096",
            "gDna": "chr9:g.132925602delT",
            "cDna": "c.348delA",
            "protein": "p.L116fs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119896,
            "transcript": "XM_011518979",
            "gDna": "chr9:g.132925602delT",
            "cDna": "c.348delA",
            "protein": "p.L116fs*2",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}